TYRA NASDAQ
Tyra Biosciences, Inc.
1W: -3.1%
1M: -1.7%
3M: +14.9%
YTD: +26.1%
1Y: +238.1%
3Y: +172.4%
$34.00
+0.22 (+0.65%)
Weekly Expected Move ±7.2%
$32
$34
$37
$40
$42
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.0B
52W Range8.75-40.65
Volume1,097,521
Avg Volume1,071,565
Beta0.79
Dividend—
Analyst Ratings
Company Info
CEOTodd Harris
Employees60
SectorHealthcare
IndustryBiotechnology
IPO Date2021-09-15
Websitetyra.bio
2656 State Street
Carlsbad, CA 92008
US
Carlsbad, CA 92008
US
619 728 4760
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.
Latest News
Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of “Moderate Buy” by Analysts
Guggenheim Starts Tyra Biosciences, Inc. (TYRA) at Buy on Strength of Lead Drug Dabogratinib
Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Warner Douglas J | A-Award | 85,000 | $33.93 | 2026-05-05 |
| Warner Douglas J | A-Award | 25,000 | — | 2026-05-05 |
| Fuhrman Alan | A-Award | 67,000 | $33.93 | 2026-05-05 |
| Fuhrman Alan | A-Award | 20,000 | — | 2026-05-05 |
| Harris Todd | A-Award | 79,000 | — | 2026-05-05 |